Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000244066 | SCV000306687 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Gene |
RCV000244066 | SCV000524725 | likely benign | not specified | 2018-01-05 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Invitae | RCV000546034 | SCV000656709 | benign | Episodic ataxia type 2; Developmental and epileptic encephalopathy, 42 | 2024-01-27 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics Inc | RCV000576692 | SCV000677208 | benign | Episodic ataxia type 2; Migraine, familial hemiplegic, 1 | 2017-05-30 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001726075 | SCV002563506 | likely benign | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | CACNA1A: BP4, BS1 |
Genome Diagnostics Laboratory, |
RCV000244066 | SCV001927921 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001726075 | SCV001964131 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV001726075 | SCV002036859 | likely benign | not provided | no assertion criteria provided | clinical testing |